Is Lantus Right for You? An Evidence-Based Breakdown

Lantus at a glance:

• Drug class: Long-acting basal insulin analog
• Manufacturer: Sanofi
• FDA approved: 2000
• Route: subcutaneous injection (SoloStar pen or vial)
• Typical frequency: once daily, same time each day
• Half-life: ~12 hours (effective duration ~24 hours)
• Cash price (US): ~$280–$340/month list; $35/month cap for Medicare beneficiaries; biosimilar (Semglee) available at lower cost

Lantus has become one of the more talked-about names in the long-acting basal insulin analog space. The clinical reality is more nuanced than the headlines suggest, and most of what matters fits in a few sentences. Insulin glargine is a long-acting analog.

What is Lantus?

Insulin glargine is a long-acting analog. After subcutaneous injection it forms microprecipitates that release slowly, producing a relatively flat 24-hour profile without a pronounced peak.

Lantus is manufactured by Sanofi. Lantus was approved by the FDA in 2000. Its approved indications include type 1 diabetes, type 2 diabetes. Off-label use happens in clinical practice but is the prescriber's responsibility.

The drug class long-acting basal insulin analog works by targeting specific receptor pathways. Here's what to expect.

How Lantus Works in the Body

Insulin glargine is a long-acting analog. After subcutaneous injection it forms microprecipitates that release slowly, producing a relatively flat 24-hour profile without a pronounced peak. The receptor target — compound-specific — drives the downstream effects users care about: 24-hour basal glucose control with reduced nocturnal hypoglycemia vs nph.

The pharmacokinetics matter for daily use. Lantus has a half-life of ~12 hours (effective duration ~24 hours), which determines how often it is dosed. The standard route of administration is subcutaneous injection (SoloStar pen or vial), and the typical schedule is once daily, same time each day.

For more detail on the underlying biology, see our breakdown of how Lantus works.

Who Uses Lantus?

Lantus is most relevant for people whose situation maps to its approved indications: type 1 diabetes; type 2 diabetes.

People who should avoid Lantus include those with the following:

• hypoglycemia

Common and Serious Side Effects

The most commonly reported side effects of Lantus include:

• hypoglycemia
• weight gain
• injection-site reactions
• lipodystrophy with poor rotation

Serious risks — uncommon but worth knowing — include:

• severe hypoglycemia
• diabetic ketoacidosis if dosing is interrupted in T1D

We have a more detailed breakdown in our Lantus side-effects guide.

Lantus vs Alternatives

Other basal insulins include Tresiba (degludec), Levemir (detemir), Toujeo (concentrated glargine), and biosimilars Semglee and Basaglar. If you are weighing Lantus against another option, our comparison pages include What Nobody Tells You About Lantus Side Effects, Lantus Outcomes Decoded: Who Responds Best and Why, How Much Does Lantus Really Cost? The Honest Breakdown.

Bottom Line

Lantus fits into a broader landscape of long-acting basal insulin analog options. The right choice for any individual depends on insurance, side-effect tolerance, dosing preference, and prescriber familiarity — usually more than on the molecule itself. Multiple randomized controlled trials support its efficacy. If you are considering Lantus, talk to a licensed clinician first — particularly if you take other medications.

Frequently Asked Questions

Related Reading

• What Nobody Tells You About Lantus Side Effects
• Lantus Outcomes Decoded: Who Responds Best and Why
• How Much Does Lantus Really Cost? The Honest Breakdown
• Lantus Dosing Patterns in the Research Literature
• What Is Humalog? Everything You Should Know Before Starting
• Is Humalog Safe? An Honest Look at the Side-Effect Profile

Sources

• Heise T et al. Insulin Pharmacokinetics and Pharmacodynamics. Diabetes Obes Metab 2017;19:3.
• American Diabetes Association. Standards of Care in Diabetes — 2024. Diabetes Care 2024;47(Suppl 1).

This page is informational only and is not medical advice. Consult a licensed clinician before starting, stopping, or changing any medication.